Your session is about to expire
← Back to Search
Annatto-derived GG for Statin-associated Myopathy (GG-statin Trial)
GG-statin Trial Summary
This trial looks at whether taking a supplement derived from the annatto plant can improve muscle health for people taking statins.
GG-statin Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowGG-statin Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.GG-statin Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You have a genetic disorder that affects your muscles and nerves.You are taking statin medication and experiencing muscle pain with or without other symptoms.You are taking a statin and recently started having muscle pain within the last 90 days.You must be at least 40 years old, regardless of whether you are male or female.You have a significant history of cancer, or serious problems with your brain or mental health, including alcohol or drug abuse.You took CoQ10 supplements within one month before the study starts.
- Group 1: Placebo
- Group 2: Low GG
- Group 3: High GG
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the anticipated results from this clinical experiment?
"This trial is aiming to observe a change in SAMS-CI at the three month mark. Secondary measurements include an analysis of blood lipids, lower body isometric strength with dynamometer readings and functional lower body strength assessed using a 50m walk loaded with weight."
Are there any open slots for enrollment in this clinical experiment?
"Clinicaltrials.gov states that this medical study, first posted on July 15th 2022 and last updated on May 10th 2022, is not currently looking for patients to join the trial. Nevertheless, there are still 30 other trials which remain open to enrollment."
Share this study with friends
Copy Link
Messenger